CASI PHARMACEUTICALS, INC. (CASIF) Net income 2020–2025
CASI PHARMACEUTICALS, INC. (CASIF) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$48.1MFY2025 · since FY2020: -$48.3M → -$48.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$48.1M | -22.4% |
| FY2024 | -$39.3M | -45.6% |
| FY2023 | -$27.0M | +34.3% |
| FY2022 | -$41.0M | -11.9% |
| FY2021 | -$36.7M | +24.1% |
| FY2020 | -$48.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice